Biotech Co. Defends Antitrust Counterclaims Against Rival <https://www.law360.com/competition/articles/2288726?nl_pk=6e763a2a-9f82-44c1-ad37-dbb872fe3785&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2025-01-27&read_main=1&nlsidx=0&nlaidx=12> By Jared Foretek Biotech company Zymo Research Corp. is defending its claims that German diagnostic competitor Qiagen GmbH's infringement suit is nothing more than an attempt to discredit a competitor, saying Zymo offered to prove it wasn't ripping off Qiagen's tech, only to have Qiagen bury "its head in the sand" and file suit. Response attached | Read full article » <https://www.law360.com/competition/articles/2288726?nl_pk=6e763a2a-9f82-44c1-ad37-dbb872fe3785&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2025-01-27&read_more=1&nlsidx=0&nlaidx=12> | Save to favorites » <https://www.law360.com/competition/articles/2288726?nl_pk=6e763a2a-9f82-44c1-ad37-dbb872fe3785&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2025-01-27&read_later=1&nlsidx=0&nlaidx=12>